These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 17694453
21. Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. Polosukhina DI, Kanyshkova TG, Doronin BM, Tyshkevich OB, Buneva VN, Boiko AN, Gusev EI, Nevinsky GA, Favorova OO. Immunol Lett; 2006 Feb 28; 103(1):75-81. PubMed ID: 16310860 [Abstract] [Full Text] [Related]
22. Myelin-basic protein-reactive specific CD4+ and CD8+ NK lymphocytes induce morphological changes in neuronal cell bodies and myelin sheaths: implications for multiple sclerosis. Zhang QY, Huang JH, Li HZ, Guo HT, Zhong YQ, Wang YM, Pei JM. Arch Med Res; 2008 Jan 28; 39(1):45-51. PubMed ID: 18067995 [Abstract] [Full Text] [Related]
23. Cryoelectron microscopy of protein-lipid complexes of human myelin basic protein charge isomers differing in degree of citrullination. Beniac DR, Wood DD, Palaniyar N, Ottensmeyer FP, Moscarello MA, Harauz G. J Struct Biol; 2000 Feb 28; 129(1):80-95. PubMed ID: 10675299 [Abstract] [Full Text] [Related]
24. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals. Berthelot L, Laplaud DA, Pettré S, Ballet C, Michel L, Hillion S, Braudeau C, Connan F, Lefrère F, Wiertlewski S, Guillet JG, Brouard S, Choppin J, Soulillou JP. Eur J Immunol; 2008 Jul 28; 38(7):1889-99. PubMed ID: 18506883 [Abstract] [Full Text] [Related]
27. Antibodies against a class II HLA-peptide complex raised by active immunization of mice with antigen mimicking peptides. Dam-Tuxen R, Riise E. Scand J Immunol; 2009 Aug 28; 70(2):93-100. PubMed ID: 19630914 [Abstract] [Full Text] [Related]
28. Design of protease-resistant myelin basic protein-derived peptides by cleavage site directed amino acid substitutions. Burster T, Marin-Esteban V, Boehm BO, Dunn S, Rotzschke O, Falk K, Weber E, Verhelst SH, Kalbacher H, Driessen C. Biochem Pharmacol; 2007 Nov 15; 74(10):1514-23. PubMed ID: 17803968 [Abstract] [Full Text] [Related]
29. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications. Polverini E, Rangaraj G, Libich DS, Boggs JM, Harauz G. Biochemistry; 2008 Jan 08; 47(1):267-82. PubMed ID: 18067320 [Abstract] [Full Text] [Related]
30. Myelin basic protein, an autoantigen in multiple sclerosis, is selectively processed by human trypsin 4. Medveczky P, Antal J, Patthy A, Kékesi K, Juhász G, Szilágyi L, Gráf L. FEBS Lett; 2006 Jan 23; 580(2):545-52. PubMed ID: 16412431 [Abstract] [Full Text] [Related]
31. [Copolymer 1 in therapy of multiple sclerosis]. Weilbach FX, Voltz R, Hohlfeld R, Hartung HP. Nervenarzt; 1995 Jun 23; 66(6):473-7. PubMed ID: 7543660 [No Abstract] [Full Text] [Related]
32. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis. Hedegaard CJ, Krakauer M, Bendtzen K, Sørensen PS, Sellebjerg F, Nielsen CH. Clin Immunol; 2008 Oct 23; 129(1):80-9. PubMed ID: 18653385 [Abstract] [Full Text] [Related]
33. Synthesis of the pentapeptide sequence 105-109 and smaller fragments of human encephalitogenic protein containing the arginine residue 107. Schafer DJ. J Chem Soc Perkin 1; 1974 Oct 23; (20):2296-300. PubMed ID: 4142636 [No Abstract] [Full Text] [Related]
35. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Bar-Or A, Vollmer T, Antel J, Arnold DL, Bodner CA, Campagnolo D, Gianettoni J, Jalili F, Kachuck N, Lapierre Y, Niino M, Oger J, Price M, Rhodes S, Robinson WH, Shi FD, Utz PJ, Valone F, Weiner L, Steinman L, Garren H. Arch Neurol; 2007 Oct 23; 64(10):1407-15. PubMed ID: 17698695 [Abstract] [Full Text] [Related]
36. Lateral reorganization of myelin lipid domains by myelin basic protein studied at the air-water interface. Hu Y, Israelachvili J. Colloids Surf B Biointerfaces; 2008 Mar 15; 62(1):22-30. PubMed ID: 17997288 [Abstract] [Full Text] [Related]
37. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Garren H, Robinson WH, Krasulová E, Havrdová E, Nadj C, Selmaj K, Losy J, Nadj I, Radue EW, Kidd BA, Gianettoni J, Tersini K, Utz PJ, Valone F, Steinman L, BHT-3009 Study Group. Ann Neurol; 2008 May 15; 63(5):611-20. PubMed ID: 18481290 [Abstract] [Full Text] [Related]
38. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer. Tamm I. Curr Opin Investig Drugs; 2008 Jun 15; 9(6):638-46. PubMed ID: 18516763 [Abstract] [Full Text] [Related]
39. Bedside to bench: betting on B cells in multiple sclerosis. Link H. Nat Med; 2008 Jun 15; 14(6):615-6. PubMed ID: 18535578 [No Abstract] [Full Text] [Related]
40. Compactification of a myelin mimetic Langmuir monolayer upon adsorption and unfolding of myelin basic protein. Khattari Z, Ruschel Y, Wen HZ, Fischer A, Fischer TM. J Phys Chem B; 2005 Mar 03; 109(8):3402-7. PubMed ID: 16851371 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]